ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $360,951,709 | +4.2% | 3,854,533 | -0.7% | 0.24% | +9.8% |
Q2 2023 | $346,451,577 | -8.5% | 3,881,362 | +9.9% | 0.22% | -14.0% |
Q1 2023 | $378,818,407 | -14.9% | 3,532,830 | -3.0% | 0.25% | -21.4% |
Q4 2022 | $445,045,721 | +12.2% | 3,643,955 | -52.5% | 0.32% | +7.1% |
Q3 2022 | $396,591,195 | +10.5% | 7,673,516 | +98.7% | 0.30% | +19.8% |
Q2 2022 | $358,967,000 | -10.4% | 3,861,259 | +13.1% | 0.25% | +27.8% |
Q1 2022 | $400,826,000 | -7.5% | 3,415,527 | +6.1% | 0.19% | +7.2% |
Q4 2021 | $433,182,000 | -16.4% | 3,219,965 | -1.0% | 0.18% | -20.3% |
Q3 2021 | $518,306,000 | +26.0% | 3,251,667 | +4.0% | 0.23% | +29.0% |
Q2 2021 | $411,387,000 | +0.8% | 3,127,171 | -1.3% | 0.18% | -5.4% |
Q1 2021 | $408,212,000 | -18.7% | 3,167,312 | +5.3% | 0.19% | -20.2% |
Q4 2020 | $501,805,000 | +9.6% | 3,008,829 | +1.4% | 0.23% | -2.5% |
Q3 2020 | $457,800,000 | +27.7% | 2,966,606 | +22.4% | 0.24% | +18.9% |
Q2 2020 | $358,607,000 | +70.6% | 2,424,688 | +29.9% | 0.20% | +38.6% |
Q1 2020 | $210,264,000 | +20.6% | 1,867,190 | +49.0% | 0.14% | +62.9% |
Q4 2019 | $174,318,000 | +454.7% | 1,253,004 | +284.1% | 0.09% | +423.5% |
Q3 2019 | $31,424,000 | +104.0% | 326,242 | -41.2% | 0.02% | +70.0% |
Q2 2017 | $15,403,000 | – | 554,865 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |